Latest news
Silence Therapeutics aims at Takeda with new data in rare blood cancer - STATSTAT · Mon, 10 Aug 2026 11:33:33 GMTSilence brings the noise to Takeda with phase 2 blood cancer win - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:31:00 GMTRebecsinib Clinical Trial Means New Options for Blood Cancer - UC San Diego TodayUC San Diego Today · Wed, 05 Aug 2026 22:21:26 GMTColorado teacher who was given months to live celebrates 10 years in remission after Omaha cancer trial - WOWTWOWT · Tue, 04 Aug 2026 03:23:00 GMTWest Virginia University Health System's clinical trial offers hope for a rare and deadly blood cancer - American Hospital AssociationAmerican Hospital Association · Mon, 03 Aug 2026 16:29:02 GMTClinical trial combines CRISPR gene editing with stem cell transplants to treat aggressive blood cancers - The Brighter Side of NewsThe Brighter Side of News · Sun, 02 Aug 2026 16:07:00 GMTBeat AML® Study Provides New Data on 14-Day vs. 28-Day Venetoclax-Azacitidine Treatment in AML - PR NewswirePR Newswire · Thu, 30 Jul 2026 18:30:00 GMT“I was offered either palliative care or the chance to take part in a clinical trial.” - Hospital Clínic BarcelonaHospital Clínic Barcelona · Wed, 29 Jul 2026 07:00:00 GMT